COYA
Live chart
What they do
Coya Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs). Its candidate product pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.
For information only · Important disclosures
Grades vs sector
No sector grades for COYA yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.
Our models
Not held by any of our 5 live models right now.
News
More newsKey stats
Valuation and fundamentals
Valuation & fundamentals
Discounted cash flow
Edit assumptions · recalculates instantly
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.00 (n/a) × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs sector
Quality & financial health
Piotroski F-score 3/9 · last two fiscal years
Analysts
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $7.9M | $-21.2M | $-10.7M |
| 2024 | $3.6M | $-14.9M | $-10.3M |
| 2023 | $6.0M | $-8.0M | $-11.2M |
| 2022 | $0 | $-12.2M | $-7.2M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR –.
Earnings
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-11 | -0.36 | -0.28 | +22.8% |
| 2026-05-12 | -0.39 | -0.32 | +17.9% |
| 2026-03-16 | -0.30 | -0.34 | -14.3% |
| 2025-11-12 | -0.30 | -0.13 | +57.0% |
| 2025-08-12 | -0.43 | -0.36 | +16.9% |
| 2025-05-13 | -0.12 | -0.44 | -252.0% |
| 2025-03-18 | -0.14 | -0.18 | -28.6% |
| 2024-11-06 | -0.41 | -0.26 | +37.4% |
Stats refreshed 2026-10-21 18:06:02 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
Independent research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app
Beta 0.9 · Oct 21, 2026